Biography of Olivier Brandicourt
Last update: 23 days agoCareer
Olivier was Director at Sanofi, and Chief Executive Officer at Bayer HealthCare.
Olivier Brandicourt is currently- Director (until May 2 2024) at BenevolentAI - View - BenevolentAI org chart
- Director at Alnylam Pharmaceuticals - View - Alnylam Pharmaceuticals org chart
- Director at Dewpoint Therapeutics - View - Dewpoint Therapeutics org chart
Create your alert
to follow the career of Olivier Brandicourt.
Education
Olivier Brandicourt has an advanced degree in cellular and immunological pathophysiology from Université René Descartes (Paris V) and a Master in Biology from University of Paris XII.
They have also studied at Université René Descartes (Paris V) :
Find more alumni from Université René Descartes (Paris V)
More about Olivier Brandicourt
Selected links
Do you need to know more about Olivier Brandicourt? More results.
Participate
Social media
- Olivier Brandicourt on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Olivier Brandicourt
The colleagues of Olivier Brandicourt
Company Colleagues
- At BenevolentAI, Olivier Brandicourt has 38 colleagues including Joerg Moeller (CEO & Director), Nigel Shadbolt (Director)…
- At Alnylam Pharmaceuticals, Olivier Brandicourt has 39 colleagues including Yvonne Greenstreet (CEO & Director), Amy Schulman (Chairman of the Board)…
- At Dewpoint Therapeutics, Olivier Brandicourt has 24 colleagues including Ameet Nathwani (CEO & Director), Regina Barzilay (Director)…
Industry Colleagues
- In the Biotechnology industry, Olivier Brandicourt has 30,481 colleagues in 2,293 companies located in 40 countries. 14,372 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Olivier Brandicourt.
Get in Touch
and ask for Olivier Brandicourt.
